Position in AXSM
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$225,433
New position
Shares Held
921
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#401
of 503 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 16%
Shared 0%
None 84%
Position in Biotechnology
Healthcare · as of Jun 30, 2026AlTi Global, Inc. holds $6,262,398 across 9 Biotechnology names. AXSM ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
20,308 | $2,302,114 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,864 | $1,162,278 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,492 | $801,129 | |
| 4 | CELC |
Celcuity Inc.
|
5,287 | $553,125 | |
| 5 | MDXG |
Mimedx Group, Inc.
|
95,493 | $367,648 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
716 | $355,658 | |
| 7 | MRNA |
Moderna, Inc.
|
3,909 | $273,746 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
This page
|
921 | $225,433 |
All Filings in AXSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $225,433 | 921 | Shares | Defined | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||